fbpx

McKinsey Helped Purdue Increase OxyContin Sales Alabama Complaint

March 22, 2021

This complaint is brought by a county and city in Alabama against McKinsey & Company, Inc. and two related McKinsey companies on the subject of opioids, citing “significantly increased costs, as well as a dramatic increase of social problems, including … drug abuse and the commission of criminal acts to obtain opioids.” The complaint says that McKinsey, a management consultant company, provided consulting services to Purdue Pharma, LP, “working to maximize sales of OxyContin and knowingly perpetuating the opioid crisis.”

Case Event File: McKinsey Helped Purdue Increase OxyContin Sales Alabama Complaint

Related to: McKinsey Helped Purdue Increase OxyContin Sales Alabama Class Action